Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$451,524
-$86,488 QoQ
Shares Held
18,751
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,828
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BBR PARTNERS, LLC holds $25,619,055 across 7 Drug Manufacturers - General names. PFE ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
53,615 | $13,491,678 | |
| 2 | JNJ |
Johnson & Johnson
|
27,913 | $7,089,064 | |
| 3 | AMGN |
Amgen Inc
|
5,580 | $2,020,629 | |
| 4 | LLY |
ELI LILLY & Co
|
1,523 | $1,826,732 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,889 | $512,184 | |
| 6 | PFE |
Pfizer Inc
This page
|
18,751 | $451,524 | |
| 7 | NVS |
Novartis AG
|
1,450 | $227,244 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $451,524 | 18,751 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $538,012 | 19,160 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $674,242 | 27,078 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $694,814 | 27,269 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $656,322 | 27,076 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $815,745 | 32,192 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,092,823 | 41,192 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,201,559 | 41,519 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,175,831 | 42,024 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,202,185 | 43,322 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,238,718 | 43,026 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,446,643 | 43,613 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,567,226 | 42,727 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,741,017 | 42,672 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,145,367 | 41,869 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,817,177 | 41,526 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,687,928 | 51,267 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,576,437 | 49,767 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,963,471 | 33,251 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,416,964 | 32,945 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,340,133 | 34,222 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,526,551 | 42,135 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,444,313 | 39,237 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,432,509 | 39,033 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $997,089 | 30,492 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,512,241 | 46,331 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||